Literature DB >> 28752179

[Clinical autopsies in Switzerland : A status report].

A-K Rodewald1, P Bode2, G Cathomas3, H Moch2.   

Abstract

BACKGROUND: The number of autopsies has been steadily declining worldwide over the past decades. The reasons for this are diverse. Legislation regarding opposition and consent rules does not appear to have had a significant impact on the autopsy rates. Above all, structural causes and the attitude of the medical profession are the reasons for this decline. The main argument for a high autopsy rate is the identification of diagnostic errors; however, diagnostic discrepancies are relatively independent of the rate of autopsies performed. At the University Hospital (UniversitätsSpital) Zurich it could be shown in a study that from 1972-2002 the frequency of relevant diagnostic discrepancies (classes I and II) decreased from 30% to 7%.
OBJECTIVE: The aim of this article is to present the necessity of a stable autopsy rate and to examine the situation of the autopsy in Switzerland.
MATERIAL AND METHODS: For this purpose, the importance of autopsies in the fields of quality assurance of medical diagnostics, cancer statistics, medical research as well as further education of doctors in Switzerland is shown. Efforts are being made by the pathologists to counteract the declining autopsy rates. RESULTS AND DISCUSSION: Declining autopsy numbers have a significant influence on cancer statistics. The rate of newly discovered tumors in autopsies in Switzerland decreased from 42% in 1980 to 17% in 2010. Pediatric autopsies are an important tool for quality assurance of medical diagnostics in neonatology and pediatrics in Switzerland, but the rate of autopsies carried out is also declining. Postmortem magnetic resonance imaging (MRI) examinations (virtopsy) could increase the acceptance of the parents for an autopsy in the future. Autopsies make an important contribution in research and in documentation of therapy-associated side effects and they are an important component of further education of the upcoming medical generations.

Entities:  

Keywords:  Autopsy; Cancer statistics; Declining autopsy numbers; Quality assurance; Virtopsy

Mesh:

Year:  2017        PMID: 28752179     DOI: 10.1007/s00292-017-0323-8

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  27 in total

Review 1.  [Autopsy and modern medicine].

Authors:  H Moch; W Wegmann; M J Mihatsch
Journal:  Praxis (Bern 1994)       Date:  1999-05-06

Review 2.  Changes in rates of autopsy-detected diagnostic errors over time: a systematic review.

Authors:  Kaveh G Shojania; Elizabeth C Burton; Kathryn M McDonald; Lee Goldman
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

3.  Value of postmortem studies in deceased neonatal and pediatric intensive care unit patients.

Authors:  Raphael Widmann; Rosmarie Caduff; Luca Giudici; Qing Zhong; Alexander Vogetseder; Romaine Arlettaz; Bernhard Frey; Holger Moch; Peter K Bode
Journal:  Virchows Arch       Date:  2016-12-14       Impact factor: 4.064

4.  [Autopsies in Switzerland, Germany and Austria: considerations about legal facts and the current situation].

Authors:  B Tag
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

5.  Common structural and epigenetic changes in the genome of castration-resistant prostate cancer.

Authors:  Terence W Friedlander; Ritu Roy; Scott A Tomlins; Vy T Ngo; Yasuko Kobayashi; Aruna Azameera; Mark A Rubin; Kenneth J Pienta; Arul Chinnaiyan; Michael M Ittmann; Charles J Ryan; Pamela L Paris
Journal:  Cancer Res       Date:  2011-12-07       Impact factor: 12.701

Review 6.  Diagnostic errors in the pediatric and neonatal ICU: a systematic review.

Authors:  Jason W Custer; Bradford D Winters; Victoria Goode; Karen A Robinson; Ting Yang; Peter J Pronovost; David E Newman-Toker
Journal:  Pediatr Crit Care Med       Date:  2015-01       Impact factor: 3.624

7.  Factors influencing discrepancies between premortem and postmortem diagnoses.

Authors:  R M Battle; D Pathak; C G Humble; C R Key; P R Vanatta; R B Hill; R E Anderson
Journal:  JAMA       Date:  1987-07-17       Impact factor: 56.272

8.  [Systemic karyomegaly with chronic interstitial nephritis. Discussion of the disease picture based on an autopsy case].

Authors:  H Moch; M Spöndlin; A Schmassmann; M J Mihatsch
Journal:  Pathologe       Date:  1994-02       Impact factor: 1.011

9.  Pathology of congenital Zika syndrome in Brazil: a case series.

Authors:  Roosecelis Brasil Martines; Julu Bhatnagar; Ana Maria de Oliveira Ramos; Helaine Pompeia Freire Davi; Silvia D'Andretta Iglezias; Cristina Takami Kanamura; M Kelly Keating; Gillian Hale; Luciana Silva-Flannery; Atis Muehlenbachs; Jana Ritter; Joy Gary; Dominique Rollin; Cynthia S Goldsmith; Sarah Reagan-Steiner; Yokabed Ermias; Tadaki Suzuki; Kleber G Luz; Wanderson Kleber de Oliveira; Robert Lanciotti; Amy Lambert; Wun-Ju Shieh; Sherif R Zaki
Journal:  Lancet       Date:  2016-06-29       Impact factor: 79.321

10.  Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression.

Authors:  L Wyler; C U Napoli; B Ingold; T Sulser; M Heikenwälder; P Schraml; H Moch
Journal:  Br J Cancer       Date:  2013-12-10       Impact factor: 7.640

View more
  3 in total

1.  Changes in Clinical and Legal Autopsy Rates in Korea from 2001 to 2015.

Authors:  Jong Pil Park; Se Hoon Kim; Sookyoung Lee; Seong Ho Yoo
Journal:  J Korean Med Sci       Date:  2019-12-09       Impact factor: 2.153

2.  Trends and risk factors for death and excess all-cause mortality among notified tuberculosis patients in the UK: an analysis of surveillance data.

Authors:  Debora Pedrazzoli; Katharina Kranzer; H Lucy Thomas; Maeve K Lalor
Journal:  ERJ Open Res       Date:  2019-12-16

3.  [A retrospective mortality analysis of natural deaths of the 65+ generation based on postmortem autopsies performed at the Institute of Legal Medicine in Frankfurt am Main during two periods].

Authors:  A Wach; C Faßbender; H Ackermann; M Parzeller
Journal:  Rechtsmedizin (Berl)       Date:  2021-03-08       Impact factor: 0.517

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.